No correlation was found between Mfn2 expression and clinical features, however, the authors pointed out that Mfn2 overexpression in BC cells significantly inhibited cell proliferation and induced apoptosis, thus suggesting that Mfn2 may act as a tumor suppressor gene and can represent a potential therapeutic target [18]. The gene discussed is MFN2; the disease is neoplasm.